Skystar Bio-Pharma (SKBI) Reports Q2 EPS of $0.37
Tweet
Share
E-mailGet Alerts SKBI Hot Sheet
Price: $0.00 --0%
Financial Fact:
COMPREHENSIVE INCOME: 4.9M
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
COMPREHENSIVE INCOME: 4.9M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Skystar Bio-Pharma (NASDAQ: SKBI) reported Q2 EPS of $0.37, versus $0.49 reported last year. Revenue for the quarter came in at $14.2 million, versus $11.3 million reported last year.
For earnings history and earnings-related data on Skystar Bio-Pharma (SKBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- Vail Resorts (MTN) Tops Q4 EPS by 1c, Offers Guidance
- Arm Holdings falls as CFO stock sale weighs on sentiment
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
